Didier Malherbe
Director/Board Member chez BANIMMO SA
Profil
Didier Malherbe is currently the Chief Executive Officer at CBRE Agency SASU, Chairman at BCI Pharma SAS, and Chairman at Bel V.
He is also an Independent Director at Banimmo SA and a Director at BioWin.
ASBL.
In the past, he was a Director at Unibioscreen SA.
Postes actifs de Didier Malherbe
Sociétés | Poste | Début |
---|---|---|
BANIMMO SA | Director/Board Member | 07/12/2016 |
BioWin ASBL
BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Director/Board Member | - |
CBRE Agency SASU
CBRE Agency SASU Real Estate DevelopmentFinance CBRE Agency SASU provides real estate brokerage service. The company was founded on December 29, 2000 and is headquartered in Paris, France. | Chief Executive Officer | 19/08/2016 |
BCI Pharma SAS
BCI Pharma SAS Miscellaneous Commercial ServicesCommercial Services BCI Pharma SAS engages in research and development in biotechnology. Its kinase platform is based on a new chemotype with phys-chem properties, able to explore a new chemical space for treating CNS, inflammation, cancer and metabolic diseases. The firm also offers medicinal chemistry, HTS platform and consultancy services. The company was founded by Elisabeth Picou and Dominique Surleraux in March 2013 and is headquartered in Grabels, France. | Chairman | 06/07/2020 |
Bel V
Bel V Miscellaneous Commercial ServicesCommercial Services Bel V offers safety assessments and inspection services. The non-profit company is based in Brussels, Belgium. The Belgian company was founded in 2007. Michel van haesendonck has been the CEO of the company since 2018. | Chairman | 01/07/2014 |
Anciens postes connus de Didier Malherbe
Sociétés | Poste | Fin |
---|---|---|
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Director/Board Member | 10/05/2011 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BANIMMO SA | Finance |
Entreprise privées | 5 |
---|---|
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Health Technology |
CBRE Agency SASU
CBRE Agency SASU Real Estate DevelopmentFinance CBRE Agency SASU provides real estate brokerage service. The company was founded on December 29, 2000 and is headquartered in Paris, France. | Finance |
BioWin ASBL
BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Commercial Services |
BCI Pharma SAS
BCI Pharma SAS Miscellaneous Commercial ServicesCommercial Services BCI Pharma SAS engages in research and development in biotechnology. Its kinase platform is based on a new chemotype with phys-chem properties, able to explore a new chemical space for treating CNS, inflammation, cancer and metabolic diseases. The firm also offers medicinal chemistry, HTS platform and consultancy services. The company was founded by Elisabeth Picou and Dominique Surleraux in March 2013 and is headquartered in Grabels, France. | Commercial Services |
Bel V
Bel V Miscellaneous Commercial ServicesCommercial Services Bel V offers safety assessments and inspection services. The non-profit company is based in Brussels, Belgium. The Belgian company was founded in 2007. Michel van haesendonck has been the CEO of the company since 2018. | Commercial Services |